That argument I can agree with except for some assumptions made.We each have to make those according to individual choice.
My first entry was based on the Covid mouse success. The resulting decision to do the Covid 012 trial confirmed its importance. The MM “No CR” Is a further confirmation.
Delayed publishing of full results for 010 and 011 suggest that answers to BP requests are being addressed. That does not assume that there is a BP deal in place. We do know that BIT225 is ‘useful’ for ART users.
What is not known yet is the final results.
Like many others I am prepared to wait.
It is interesting to know whether 25 November 2024 was a timely choice of date for option maturity?
Hopefully …….
Not much longer now
Poweful Words by our CEO, page-66
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.002(7.14%) |
Mkt cap ! $23.46M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.6¢ | $51.84K | 1.992M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 198646 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 199924 | 1 |
View Market Depth
| Last trade - 15.36pm 30/08/2024 (20 minute delay) ? |
| BIT (ASX) Chart |